Barclays’s CapForce IBD 50 ETF FFTY Stock Holding History

Barclays’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,061	Closed	-$50K	–	4305
2021 Q3	$50K	Buy	+1,061	New	+$49.6K	﹤0.01%	4108

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays's FFTY Position: Q4 2021 in Review

Barclays sold out of CapForce IBD 50 ETF (FFTY) in Q4 2021, closing a stake of 1,061 shares — an estimated $50K sold.

Barclays first reported a position in FFTY in Q3 2021 and held it in 1 quarter. The position peaked at $50K in Q3 2021. 79 funds tracked by Wall St. Rank hold FFTY as of Q4 2021.

Barclays reported no remaining CapForce IBD 50 ETF position as of Q4 2021 after selling out during the quarter.
Barclays sold 1,061 CapForce IBD 50 ETF shares in Q4 2021, an estimated $50K.
Barclays first reported a position in CapForce IBD 50 ETF in Q3 2021 and held it in 1 quarter.
Barclays's CapForce IBD 50 ETF position peaked at $50K in Q3 2021.
79 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.